The STEP 1 trial (published in the New England Journal of Medicine) documented mean weight reductions of 14.9% with once-weekly semaglutide 2.4 mg compared to 2.4% with placebo, with corresponding improvements in waist circumference of approximately 13.5 cm with semaglutide versus 4.1 cm with placebo after 68 weeks
According to Jonathan Kaplan, MD, a board-certified plastic surgeon and GLP-1 expert at Pacific Heights Plastic Surgery in San Francisco, while constipation is not the most common side effect of Ozempic, some patients may experience less frequent bowel movements than usual while on the medication
Our medical team ensures that a GLP-1 treatment is appropriate for you in the first place, reviewing your health history and any potential contraindications
Tysnes O, Kenborg L, Herlofson K, Steding-Jessen M, Horn A, Olsen JH, et al
In another study, alogliptin (40 mg/kg, i.p
Semaglutide uses a gradual titration approach, starting at a low dose and increasing over time